(19)
(11) EP 2 778 156 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
22.02.2017 Bulletin 2017/08

(45) Mention of the grant of the patent:
30.11.2016 Bulletin 2016/48

(21) Application number: 14171857.7

(22) Date of filing: 26.05.2009
(51) International Patent Classification (IPC): 
C07D 213/82(2006.01)
C07D 401/14(2006.01)
C07D 413/14(2006.01)
C07D 417/14(2006.01)
C07D 487/04(2006.01)
A61K 31/455(2006.01)
A61P 9/00(2006.01)
A61P 35/00(2006.01)
C07D 401/12(2006.01)
C07D 413/12(2006.01)
C07D 417/12(2006.01)
C07D 471/04(2006.01)
C07D 498/04(2006.01)
A61P 25/00(2006.01)
A61P 37/00(2006.01)

(54)

Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states

Phenoxypyridinylamidderivate und ihre Verwendung zur Behandlung von PDE4-vermittelten Krankheitszuständen

Dérivés de phénoxypyridinylamide et leur utilisation dans le traitement d'états pathologiques induits par PDE4


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

(30) Priority: 27.05.2008 US 128939 P

(43) Date of publication of application:
17.09.2014 Bulletin 2014/38

(62) Application number of the earlier application in accordance with Art. 76 EPC:
09754139.5 / 2297106

(73) Proprietors:
  • AstraZeneca AB
    151 85 Södertälje (SE)
    Designated Contracting States:
    AT BE BG CH CY CZ DK EE ES FI GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR 
  • Galderma S.A.
    6330 Cham (CH)
    Designated Contracting States:
    DE FR GB 

(72) Inventors:
  • Andrews, Glen
    Macclesfield, Cheshire SK10 4TG (GB)
  • Cox, Rhona, Jane
    SE 431 83 Mölndal (SE)
  • De Savi, Christopher
    Waltham, Massachusetts 02451 (US)
  • Meghani Premji
    Macclesfield, Cheshire SK10 4TG (GB)
  • Sanganee, Hitesh Jayantilal
    Macclesfield, Cheshire SK10 4TG (GB)
  • Warner, Daniel, Jon
    Waltham, Massachusetts 02451 (US)

(74) Representative: Lowry, Rachel Maria 
AstraZeneca UK Limited, Intellectual Property, Mereside, Alderley Park
Macclesfield, Cheshire SK10 4TG
Macclesfield, Cheshire SK10 4TG (GB)


(56) References cited: : 
US-A1- 2003 220 366
US-A1- 2005 020 639
US-A1- 2005 020 626
US-A1- 2005 032 838
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).